NCT05456685 · Interventional trial
Mirvetuximab Soravtansine (MIRV) With Carboplatin in Second-line Treatment of Folate Receptor Alpha (FRα) Expressing, Platinum-sensitive Epithelial Ovarian Cancer
Overall registry status Active not recruiting
Phase 2
Conditions Fallopian Tube Cancer, High Grade Ovarian Cancer, Primary Peritoneal Cancer
Delaware Valley sites
- Md Anderson Cancer Center At Cooper /ID# 268885 · Camden, NJ · Camden County
First posted
Registry updated
Added to the directory